New therapies deserve diverse funding sources

Getting financing can be difficult. This news article from the Worcester Telegram & Gazette demonstrates the importance of SBIR funding.
“Not all start-up companies have been able to tap into venture capital to fund their businesses. Mr. Prescott of Crescent Innovations has secured federal Small Business Innovation Research funding, grants and money from [...]

Putting the “I” Back into SBIR

Putting the “I” back — that is the “I” in innovation. While we consider SBIR program to be critical to the commercialization of biotechnology for our industry, it is clear that others do not share this view ordiffer on the ways in which this problem should be fixed. For example, Kristie Prinz wrote [...]

Welcome

My name is Cartier Esham.  I am the new Director of Health and Regulatory Affairs for BIO’s Emerging Companies.  The purpose of this blog is to generate discussion surrounding important issues facing the biotechnology industry and patient focused organizations.  Before coming to Washington, D.C., I received my doctorate in microbial ecology and have a great [...]